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Cell-derived microparticles (MPs) are 0.1 to 1 micron extracellular vesicles (EVs), budding off cellular plasma 
membranes under stress or activation. MPs play an important role in cell-to-cell communication by transferring 
cargo from parent to target cells. Among circulating MPs, megakaryocyte-derived MPs (MkMPs) are the most 
abundant MPs in circulation (1). We have demonstrated that, in vitro, MkMPs specifically targeted and were 
taken up by human hematopoietic stem & progenitor cells (HSPCs) via fusion or endocytosis following specific 
receptor recognition (2). MkMPs transfer cargo to HSPCs and induce potent Mk differentiation of HSPCs in the 
absence of thrombopoietin (3). Here, we explored the capability of human MkMPs to transfer DNA and siRNA to 
HSPCs, and developed MkMP-based strategies for gene therapy. From our current protocol, we were able to 
achieve loading of plasmid DNA (pGFPns: encoding eGFP) into over 80% of MPs and functional delivery to 
HSPCs though co-culture to perform eGFP expression. DNA delivery efficiency were increased by optimized co-
culture methods, chemically via fusogens to enhance membrane fusion, and physically to enhance contact 
between MPs and HSPCs. As a result, we were able to make possible that more than 20% of HSPCs express 
GFP. Functional RNA delivery was also studied by examining the impact of siR-MYB mediated c-myb silencing 
in enhancing Mk differentiation of CD34+ cells. Our data demonstrate that MkMP-based delivery of siR-MYB to 
HSPCs enabled c-myb silencing that resulted in enhanced Mk differentiation beyond that of unloaded MkMPs, 
as assessed by a 29% increase of CD41 expression (an Mk marker), indicating functional siRNA delivery. To 
sum, functional pDNA and siRNA delivery to HSPCs via MkMPs demonstrate the potential of this delivery 
system for targeting the stem-cell compartment, suggesting that MkMPs constitute a potentially useful 
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